Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy
- PMID: 12586284
- DOI: 10.1016/s0002-9149(02)03291-5
Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy
Comment on
-
Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial).Am J Cardiol. 2002 Sep 15;90(6):585-90. doi: 10.1016/s0002-9149(02)02560-2. Am J Cardiol. 2002. PMID: 12231081 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical